GO:1905765 negative regulation of protection from non-homologous end joining at telomere: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905765 describes the biological process that reduces the protection of telomeres from non-homologous end joining (NHEJ), a key mechanism preventing telomere fusions and genomic instability.
• POT1 proteins are central to telomere protection and their distinct functions regulate telomerase recruitment, influencing NHEJ protection.
• Rif1 and Rif2 are conserved regulators that protect telomeres from NHEJ and are hijacked by telomeres in yeasts.
• The MRX complex plays multiple roles in resection of Yku- and Rif2-protected DNA ends, impacting NHEJ protection.
• Telomerase, recombination machinery, and Rap1 play redundant roles in yeast telomere protection, highlighting layered regulation.
• Dysregulation of this process is linked to cancer and aging, making it a target for therapeutic intervention [1,2].
Description
Telomeres are specialized nucleoprotein structures that cap chromosome ends and protect them from being recognized as DNA double-strand breaks. The protection from non-homologous end joining (NHEJ) at telomeres is crucial to prevent chromosome fusions and maintain genomic stability. GO:1905765, negative regulation of protection from non-homologous end joining at telomere, refers to any process that stops, prevents, or reduces the frequency, rate, or extent of protection from NHEJ at telomeres. This process is essential for understanding how cells balance telomere protection and repair mechanisms. Researchers study this term to elucidate mechanisms of genome maintenance, aging, and cancer development. The regulation involves a complex interplay of shelterin components, such as POT1, and accessory factors like Rif1 and Rif2, which modulate the accessibility of telomeres to NHEJ machinery [1,2].
negative regulation of protection from non-homologous end joining at telomere At A Glance
| GO ID | GO:1905765 |
|---|---|
| GO term | negative regulation of protection from non-homologous end joining at telomere |
| Ontology | biological_process |
| Synonym | inhibition of protection from NHEJ-mediated telomere fusion |
| Major function | Reduces the protection of telomeres from NHEJ, potentially leading to telomere fusions |
| Related genes | POT1, Rif1, Rif2, Rap1, MRX complex components |
| Associated diseases | Cancer, premature aging syndromes |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, library screening |
What Is GO:1905765?
GO:1905765 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of protection from non-homologous end joining at telomere. In other words, it negatively regulates the shielding of telomeres from NHEJ-mediated fusion, thereby promoting the exposure of telomeres to NHEJ when protection is reduced. This process is a biological regulation that can be triggered under specific conditions, such as during telomere dysfunction or in certain cell cycle stages [1,5].
Why Is negative regulation of protection from non-homologous end joining at telomere Important in Cell Biology?
Understanding GO:1905765 is critical because the balance between telomere protection and NHEJ accessibility directly impacts genome stability. When protection is reduced, telomeres become susceptible to NHEJ, leading to chromosome fusions, which can drive oncogenesis or cellular senescence [1,2]. This process is also relevant for aging and cancer therapies targeting telomere maintenance.
• Prevents chromosomal instability by regulating telomere fusions.
• Influences telomerase recruitment and activity.
• Plays a role in the DNA damage response at telomeres.
• Implicated in cancer development through telomere dysfunction.
• Contributes to aging and senescence mechanisms.
• Provides targets for anti-cancer therapies.
• Helps understand species-specific telomere regulation.
• Relevant for fungal pathogenicity studies.
• Key for studying NHEJ pathway choice.
• Potential biomarker for telomere-related disorders.
What Happens During negative regulation of protection from non-homologous end joining at telomere?
Initiation by Telomere Dysfunction or Cell Cycle Signals
In simple terms: When telomeres are damaged or the cell cycle requires it, protection is reduced.
Negative regulation of telomere protection from NHEJ can be initiated by telomere shortening, uncapping, or specific cell cycle phases. POT1 proteins, which normally bind telomeric DNA, may dissociate or be modified, reducing protection. In yeast, Rif1 and Rif2 are removed or inactivated, allowing NHEJ factors access to telomeres.
Modification of Shelterin Components
In simple terms: Proteins that shield telomeres are altered to lower their protective function.
Shelterin components such as POT1, TRF1, and TRF2 undergo post-translational modifications or competitive binding that diminish their ability to block NHEJ. For example, POT1 phosphorylation may reduce its affinity for telomeric DNA, leading to increased NHEJ. In yeast, Rap1 and Rif proteins are targeted by kinases, affecting their protective roles.
Recruitment of NHEJ Machinery
In simple terms: Repair proteins that fuse DNA ends are recruited to telomeres.
Once protection is reduced, NHEJ factors such as Ku70/Ku80, DNA ligase IV, and XRCC4 are recruited to telomeres. The MRX complex in yeast plays a role in resection of protected DNA ends, facilitating NHEJ. This recruitment can lead to telomere fusions if not properly regulated.
Outcome: Telomere Fusions or Checkpoint Activation
In simple terms: The result is either chromosome fusions or cell cycle arrest.
Reduced protection can result in NHEJ-mediated telomere fusions, causing genomic instability. Alternatively, checkpoint activation may occur, leading to senescence or apoptosis. In fungal pathogens, similar processes affect development and pathogenicity.
Key Genes Involved in GO:1905765 negative regulation of protection from non-homologous end joining at telomere
Key genes and proteins involved in GO:1905765 include shelterin components, yeast-specific regulators, and NHEJ factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POT1 | Binds telomeric ssDNA, protects from NHEJ | Regulates telomerase recruitment and telomere protection |
| Rif1 | Yeast telomere length regulator and NHEJ protector | Conserved regulator hijacked by telomeres |
| Rif2 | Yeast telomere protection factor | Works with Rif1 to inhibit NHEJ |
| Rap1 | Shelterin component in yeast | Redundant roles in telomere protection |
| MRX complex (Mre11, Rad50, Xrs2) | Resection of DNA ends | Plays multiple functions in resection of Yku- and Rif2-protected ends |
| Yku70/80 | NHEJ factor | Binds telomeres and influences protection |
| Telomerase | Elongates telomeres | Redundant with recombination machinery in protection |
| TRF1 | Shelterin component | Negative regulator of telomere length |
| TRF2 | Shelterin component | Protects telomeres from NHEJ |
| FgRad50 | Fungal Rad50 homolog | Regulates development and DNA damage response |
| DNA Ligase IV | NHEJ ligase | Catalyzes telomere fusions when protection lost |
| XRCC4 | NHEJ factor | Complexes with Ligase IV |
| Ku70 | NHEJ factor | Binds DNA ends |
| Ku80 | NHEJ factor | Binds DNA ends |
| ATM | DNA damage kinase | Signals telomere dysfunction |
| ATR | DNA damage kinase | Responds to telomere uncapping |
| RPA | ssDNA binding protein | Involved in resection at telomeres |
How Is negative regulation of protection from non-homologous end joining at telomere Regulated?
The process of negative regulation of protection from NHEJ at telomeres is regulated by multiple mechanisms. In yeast, Rif1 and Rif2 are key regulators that are themselves controlled by cell cycle kinases and telomere length. POT1 in humans is regulated by phosphorylation and interaction with TPP1, affecting its ability to protect telomeres. Additionally, the MRX complex and Yku proteins modulate the accessibility of telomeres to NHEJ. Redundancy with telomerase and recombination machinery ensures robust protection under varying conditions.
negative regulation of protection from non-homologous end joining at telomere and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POT1 | Melanoma, CLL | CRISPR knockout in melanoma cell lines |
| Rif1 | Aging, cancer | Yeast knockout and overexpression |
| FgRad50 | Fungal pathogenicity | Fusarium graminearum knockout |
| TRF2 | Dyskeratosis congenita | Knock-in of patient mutations |
| Ku70/80 | Cancer predisposition | Point mutation in NHEJ factors |
Cancer
Dysregulation of telomere protection from NHEJ can lead to chromosome fusions and genomic instability, hallmarks of cancer. POT1 mutations are associated with familial melanoma and chronic lymphocytic leukemia. Targeting this process may sensitize cancer cells to therapies that induce telomere dysfunction.
Aging and Premature Aging Syndromes
Reduced telomere protection can accelerate aging by promoting senescence. In yeast models, loss of Rif1 and Rif2 leads to shortened lifespan. In humans, mutations in shelterin components cause dyskeratosis congenita and other premature aging disorders.
Fungal Pathogenicity
In Fusarium graminearum, FgRad50 regulates development, pathogenicity, and DNA damage response, linking telomere protection to fungal virulence. This suggests that targeting NHEJ protection could be a strategy for antifungal development.
From negative regulation of protection from non-homologous end joining at telomere-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does POT1 knockout reduce telomere protection? | CRISPR knockout in human cell lines |
| How do point mutations in POT1 affect NHEJ? | Point mutation knock-in |
| Can overexpression of Rif1 restore protection? | Overexpression in yeast |
| What is the role of MRX in resection? | Knockout of Mre11 in yeast |
| Does FgRad50 affect pathogenicity? | Knockout in Fusarium graminearum |
| Can tagged POT1 track telomere dynamics? | Tagged knock-in with fluorescent protein |
How to Study the negative regulation of protection from non-homologous end joining at telomere Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Gene function loss | Identify negative regulators |
| Point mutation | Specific residue function | Dissect protein domains |
| Knock-in | Protein localization and dynamics | Live-cell imaging |
| Overexpression | Gain-of-function effects | Test sufficiency |
| Library screening | Genome-wide candidates | Discover new regulators |
| Bioinformatics | Pathway enrichment | Analyze CRISPR screen data |
| Proteomics | Protein interactions | Identify shelterin complexes |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify genes that negatively regulate telomere protection from NHEJ. Libraries targeting shelterin components and NHEJ factors are used to assess telomere fusions.
Point Mutation Analysis
Introducing point mutations in POT1 or Rif1 via CRISPR can reveal specific residues required for protection. These mutations help dissect domain functions.
Knock-in Reporter Systems
Knock-in of fluorescent tags at telomere protection genes allows live-cell imaging of telomere dynamics and NHEJ events.
Overexpression Studies
Overexpressing protective factors like Rif1 or POT1 can test sufficiency in preventing NHEJ. This is often done in yeast or human cells.
How CRISPR Can Be Used to Study GO:1905765 negative regulation of protection from non-homologous end joining at telomere
Knockout
CRISPR knockout of POT1 or Rif1 can abolish telomere protection, leading to increased NHEJ and telomere fusions. This models loss-of-function mutations in cancer.
Point Mutation
Point mutations in the DNA-binding domain of POT1 can specifically disrupt telomere protection without affecting other functions, allowing precise structure-function analysis.
Knock-in
Knock-in of tagged versions of shelterin proteins enables tracking of telomere protection dynamics in real time.
Overexpression
Overexpression of Rif1 or POT1 can enhance protection from NHEJ, providing insights into dosage effects and potential therapeutic strategies.
How EDITGENE Supports negative regulation of protection from non-homologous end joining at telomere Research
Researchers studying negative regulation of protection from non-homologous end joining at telomere-related genes often need to determine whether a candidate gene is causally involved in telomere protection or NHEJ regulation. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of protection from non-homologous end joining at telomere research.
Frequently Asked Questions About negative regulation of protection from non-homologous end joining at telomere
What is GO:1905765?
GO:1905765 is a Gene Ontology term for the biological process that negatively regulates the protection of telomeres from non-homologous end joining (NHEJ), potentially leading to telomere fusions.
What genes are involved in negative regulation of protection from non-homologous end joining at telomere?
Key genes include POT1, Rif1, Rif2, Rap1, and components of the MRX complex, as well as NHEJ factors like Ku70/80 and DNA ligase IV [1,2,5].
How does POT1 regulate telomere protection?
POT1 binds telomeric single-stranded DNA and protects it from NHEJ; its dissociation or modification reduces protection, allowing NHEJ to access telomeres.
What is the role of Rif1 in telomere protection?
Rif1 is a conserved regulator that protects telomeres from NHEJ in yeast; its removal leads to increased NHEJ-mediated fusions.
How is negative regulation of protection from NHEJ at telomeres studied?
Researchers use CRISPR knockout, point mutations, knock-in reporters, overexpression, and library screening to study this process [1,3].
What diseases are associated with defective telomere protection?
Defective telomere protection is linked to cancer, premature aging syndromes like dyskeratosis congenita, and fungal pathogenicity [1,2,4].
Can CRISPR be used to model telomere protection defects?
Yes, CRISPR knockout of POT1 or Rif1 can model loss of protection and increased NHEJ, useful for cancer and aging research [1,2].
What is the MRX complex and its role?
The MRX complex (Mre11-Rad50-Xrs2) in yeast plays multiple roles in resection of protected DNA ends, influencing NHEJ at telomeres.
How does telomerase relate to telomere protection?
Telomerase, along with recombination machinery and Rap1, plays redundant roles in yeast telomere protection, ensuring robustness.
What experimental models are used for GO:1905765?
Common models include human cell lines for POT1 studies, yeast for Rif1/Rif2, and Fusarium graminearum for FgRad50 [1,2,4].
Conclusion
GO:1905765, negative regulation of protection from non-homologous end joining at telomere, is a critical process for genome stability. Its dysregulation contributes to cancer and aging, making it a prime target for therapeutic intervention. Continued research using advanced CRISPR models will unravel the precise mechanisms and identify new drug targets.
References
- 1. Gu P et al.. 2021. Distinct functions of POT1 proteins contribute to the regulation of telomerase recruitment to telomeres.. Nat Commun 12(1):5514 PMID: 34535663
- 2. Mattarocci S et al.. 2016. Rif1: A Conserved Regulator of DNA Replication and Repair Hijacked by Telomeres in Yeasts.. Front Genet 7:45 PMID: 27066066
- 3. Kabaha MM et al.. 2021. Telomerase, the recombination machinery and Rap1 play redundant roles in yeast telomere protection.. Curr Genet 67(1):153-163 PMID: 33156376
- 4. Zhang C et al.. 2019. FgRad50 Regulates Fungal Development, Pathogenicity, Cell Wall Integrity and the DNA Damage Response in Fusarium graminearum.. Front Microbiol 10:2970 PMID: 31998262
- 5. Bonetti D et al.. 2010. The MRX complex plays multiple functions in resection of Yku- and Rif2-protected DNA ends.. PLoS One 5(11):e14142 PMID: 21152442
